Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

| Create an account https://orcid.org

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

1-25 of 54 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3

A Multistage, Multiarmed, Double-Blind Placebo-Controlled Human Transdermal Vitamin D Supplement Study (TransVitD)
Hibbard T, Andriollo P, Lim CH, Guo Q, Lawrence K, Coker B, Malek R, Douiri A, Alhnan MA, Jones S
Research Square, 22 Mar 2024
Cited by: 0 articles | PPR: PPR826396
Add to export list Preprint v1
Laser-cutting: A novel alternative approach for point-of-care manufacturing of bespoke tablets.
Liu Y, M Leonova A, Royall PG, Abdillah Akbar BVEB, Cao Z, Jones SA, Isreb A, Hawcutt DB, Alhnan MA
Int J Pharm, 647:123518, 16 Oct 2023
Cited by: 1 article | PMID: 37852311
Add to export list
In Vitro and In Vivo Evaluation of Dark Chocolate as Age-appropriate Oral Matrix.
Al-Kabariti AY, Arafat BT, Oriquat GA, Možná P, Jaidy H, Rehmani A, Patel K, Al-Qinna N, Alhnan MA
Eur J Pharm Sci, 192:106646, 19 Nov 2023
Cited by: 0 articles | PMID: 37989467
Add to export list
Computer numerical control (CNC) carving as an on-demand point-of-care manufacturing of solid dosage form: A digital alternative method for 3D printing.
Kaba K, Purnell B, Liu Y, Royall PG, Alhnan MA
Int J Pharm, 645:123390, 06 Sep 2023
Cited by: 1 article | PMID: 37683980
Add to export list
Towards point-of-care manufacturing and analysis of immediate-release 3D printed hydrocortisone tablets for the treatment of congenital adrenal hyperplasia.
Yang TL, Stogiannari M, Janeczko S, Khoshan M, Lin Y, Isreb A, Habashy R, Giebułtowicz J, Peak M, Alhnan MA
Int J Pharm, 642:123072, 24 May 2023
Cited by: 6 articles | PMID: 37230368
Add to export list
The use of near-infrared as process analytical technology (PAT) during 3D printing tablets at the point-of-care.
Yang TL, Szewc J, Zhong L, Leonova A, Giebułtowicz J, Habashy R, Isreb A, Alhnan MA
Int J Pharm, 642:123073, 24 May 2023
Cited by: 2 articles | PMID: 37230372
Add to export list
The use of Special-Order products in England between 2012 and 2020: An insight into the need for Point-of-Care manufacturing.
O'Donovan A, Duncan JC, Li KY, Del-Nevo L, Gill A, Peak M, Alhnan MA
Int J Pharm, 637:122801, 05 Mar 2023
Cited by: 0 articles | PMID: 36878418
Add to export list
Needleless administration of advanced therapies into the skin via the appendages using a hypobaric patch.
Benaouda F, Inacio R, Lim CH, Park H, Pitcher T, Alhnan MA, Aly MMS, Al-Jamal KT, Chan KL, Gala RP, Sebastia-Saez D, Cui L, Chen T, Keeble J, Jones SA
Proc Natl Acad Sci U S A, 119(18):e2120340119, 28 Apr 2022
Cited by: 3 articles | PMID: 35482922 | PMCID: PMC9170139
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Simultaneous pulmonary administration of celecoxib and naringin using a nebulization-friendly nanoemulsion: A device-targeted delivery for treatment of lung cancer.
Said-Elbahr R, Nasr M, Alhnan MA, Taha I, Sammour O
Expert Opin Drug Deliv, 19(5):611-622, 19 May 2022
Cited by: 9 articles | PMID: 35538642
Add to export list
Creating Acceptable Tablets 3D (CAT 3D): A Feasibility Study to Evaluate the Acceptability of 3D Printed Tablets in Children and Young People.
Bracken L, Habashy R, McDonough E, Wilson F, Shakeshaft J, Ohia U, Garcia-Sorribes T, Isreb A, Alhnan MA, Peak M
Pharmaceutics, 14(3):516, 25 Feb 2022
Cited by: 6 articles | PMID: 35335892 | PMCID: PMC8954179
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
A Novel Multilayer Natural Coating for Fed-State Gastric Protection.
Habashy R, Khoder M, Isreb A, Alhnan MA
Pharmaceutics, 14(2):283, 26 Jan 2022
Cited by: 1 article | PMID: 35214016 | PMCID: PMC8879697
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The potential of nanotherapeutics to target brain tumors: current challenges and future opportunities.
Garanti T, Alhnan MA, Wan KW
Nanomedicine (Lond), 16(21):1833-1837, 12 Jul 2021
Cited by: 1 article | PMID: 34251278
Add to export list
Impact of nanosizing on the formation and characteristics of polymethacrylate films: micro- versus nano-suspensions.
Yousaf SS, Isreb A, Khan I, Mewsiga E, Elhissi A, Ahmed W, Alhnan MA
Pharm Dev Technol, 26(7):729-739, 07 Jun 2021
Cited by: 2 articles | PMID: 34034606
Add to export list
Controlling drug release with additive manufacturing-based solutions.
Patel SK, Khoder M, Peak M, Alhnan MA
Adv Drug Deliv Rev, 174:369-386, 23 Apr 2021
Cited by: 14 articles | PMID: 33895213
Add to export list Review
Solvent-free temperature-facilitated direct extrusion 3D printing for pharmaceuticals.
Kuźmińska M, Pereira BC, Habashy R, Peak M, Isreb M, Gough TD, Isreb A, Alhnan MA
Int J Pharm, 598:120305, 01 Feb 2021
Cited by: 13 articles | PMID: 33540022
Add to export list
An innovative wax-based enteric coating for pharmaceutical and nutraceutical oral products.
Habashy R, Khoder M, Zhang S, Pereira B, Bohus M, Tzu-Wen Wang J, Isreb A, Alhnan MA
Int J Pharm, 591:119935, 01 Oct 2020
Cited by: 3 articles | PMID: 33011248
Add to export list
Can filaments be stored as a shelf-item for on-demand manufacturing of oral 3D printed tablets? An initial stability assessment.
Okwuosa TC, Sadia M, Isreb A, Habashy R, Peak M, Alhnan MA
Int J Pharm, 600:120442, 03 Mar 2021
Cited by: 6 articles | PMID: 33675925
Add to export list
Temperature and solvent facilitated extrusion based 3D printing for pharmaceuticals.
Dores F, Kuźmińska M, Soares C, Bohus M, A Shervington L, Habashy R, Pereira BC, Peak M, Isreb A, Alhnan MA
Eur J Pharm Sci, 152:105430, 17 Jun 2020
Cited by: 9 articles | PMID: 32562691
Add to export list
Additive Manufacturing of a Point-of-Care "Polypill:" Fabrication of Concept Capsules of Complex Geometry with Bespoke Release against Cardiovascular Disease.
Pereira BC, Isreb A, Isreb M, Forbes RT, Oga EF, Alhnan MA
Adv Healthc Mater, 9(13):e2000236, 08 Jun 2020
Cited by: 14 articles | PMID: 32510859
Add to export list
RGD-decorated solid lipid nanoparticles enhance tumor targeting, penetration and anticancer effect of asiatic acid.
Garanti T, Alhnan MA, Wan KW
Nanomedicine (Lond), 15(16):1567-1583, 03 Jul 2020
Cited by: 5 articles | PMID: 32618517
Add to export list
A novel natural GRAS-grade enteric coating for pharmaceutical and nutraceutical products.
Khoder M, Schropp V, Zeitler S, Pereira B, Habashy R, Royall PG, Wang JT, Alhnan MA
Int J Pharm, 584:119392, 04 May 2020
Cited by: 6 articles | PMID: 32376448
Add to export list
Embedded 3D Printing of Novel Bespoke Soft Dosage Form Concept for Pediatrics.
Rycerz K, Stepien KA, Czapiewska M, Arafat BT, Habashy R, Isreb A, Peak M, Alhnan MA
Pharmaceutics, 11(12):E630, 26 Nov 2019
Cited by: 23 articles | PMID: 31779123 | PMCID: PMC6956071
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
3D printed oral theophylline doses with innovative 'radiator-like' design: Impact of polyethylene oxide (PEO) molecular weight.
Isreb A, Baj K, Wojsz M, Isreb M, Peak M, Alhnan MA
Int J Pharm, 564:98-105, 08 Apr 2019
Cited by: 34 articles | PMID: 30974194
Add to export list
'Temporary Plasticiser': A novel solution to fabricate 3D printed patient-centred cardiovascular 'Polypill' architectures.
Pereira BC, Isreb A, Forbes RT, Dores F, Habashy R, Petit JB, Alhnan MA, Oga EF
Eur J Pharm Biopharm, 135:94-103, 21 Dec 2018
Cited by: 43 articles | PMID: 30579852
Add to export list
From 'fixed dose combinations' to 'a dynamic dose combiner': 3D printed bi-layer antihypertensive tablets.
Sadia M, Isreb A, Abbadi I, Isreb M, Aziz D, Selo A, Timmins P, Alhnan MA
Eur J Pharm Sci, 123:484-494, 21 Jul 2018
Cited by: 31 articles | PMID: 30041029
Add to export list

1-25 of 54 results

1 2 3

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

A Multistage, Multiarmed, Double-Blind Placebo-Controlled Human Transdermal Vitamin D Supplement Study (TransVitD)

Laser-cutting: A novel alternative approach for point-of-care manufacturing of bespoke tablets.

In Vitro and In Vivo Evaluation of Dark Chocolate as Age-appropriate Oral Matrix.

Computer numerical control (CNC) carving as an on-demand point-of-care manufacturing of solid dosage form: A digital alternative method for 3D printing.

Towards point-of-care manufacturing and analysis of immediate-release 3D printed hydrocortisone tablets for the treatment of congenital adrenal hyperplasia.

The use of near-infrared as process analytical technology (PAT) during 3D printing tablets at the point-of-care.

The use of Special-Order products in England between 2012 and 2020: An insight into the need for Point-of-Care manufacturing.

Needleless administration of advanced therapies into the skin via the appendages using a hypobaric patch.

Simultaneous pulmonary administration of celecoxib and naringin using a nebulization-friendly nanoemulsion: A device-targeted delivery for treatment of lung cancer.

Creating Acceptable Tablets 3D (CAT 3D): A Feasibility Study to Evaluate the Acceptability of 3D Printed Tablets in Children and Young People.

A Novel Multilayer Natural Coating for Fed-State Gastric Protection.

The potential of nanotherapeutics to target brain tumors: current challenges and future opportunities.

Impact of nanosizing on the formation and characteristics of polymethacrylate films: micro- versus nano-suspensions.

Controlling drug release with additive manufacturing-based solutions.

Solvent-free temperature-facilitated direct extrusion 3D printing for pharmaceuticals.

An innovative wax-based enteric coating for pharmaceutical and nutraceutical oral products.

Can filaments be stored as a shelf-item for on-demand manufacturing of oral 3D printed tablets? An initial stability assessment.

Temperature and solvent facilitated extrusion based 3D printing for pharmaceuticals.

Additive Manufacturing of a Point-of-Care "Polypill:" Fabrication of Concept Capsules of Complex Geometry with Bespoke Release against Cardiovascular Disease.

RGD-decorated solid lipid nanoparticles enhance tumor targeting, penetration and anticancer effect of asiatic acid.

A novel natural GRAS-grade enteric coating for pharmaceutical and nutraceutical products.

Embedded 3D Printing of Novel Bespoke Soft Dosage Form Concept for Pediatrics.

3D printed oral theophylline doses with innovative 'radiator-like' design: Impact of polyethylene oxide (PEO) molecular weight.

'Temporary Plasticiser': A novel solution to fabricate 3D printed patient-centred cardiovascular 'Polypill' architectures.

From 'fixed dose combinations' to 'a dynamic dose combiner': 3D printed bi-layer antihypertensive tablets.

Partnerships & funding